ReviewUrologie (Heidelberg, Germany)2026
[Immune checkpoint inhibition plus Bacillus Calmette-Guerin (BCG) therapy in BCG-naive high-risk non-muscle-invasive bladder cancer: a critical review in the context of current evidence].
Georgios Gakis et al.PubMed ↗Publisher ↗
No numbers read from the abstract.